Consistent with previous research demonstrating high PD-L1 expression in glioblastomas, our study found PD-L1 expressed in six (66.7%) grade 2 gliomas and 27 (75%) grade 4 gliomas [19,20]. The gene discussed is CD274; the disease is central nervous system cancer.